Variant report

Variant	esv2422265
Chromosome Location	chr9:17396711-17598187
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:17531669-17532065	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:17531774-17531980	K562	blood:	n/a	n/a
3	ATF2	chr9:17578879-17579258	H1-hESC	embryonic stem cell:	n/a	chr9:17579056-17579070
4	BACH1	chr9:17469243-17469263	K562	blood:	n/a	n/a
5	BACH1	chr9:17579465-17579665	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr9:17578520-17578521	H1-hESC	embryonic stem cell:	n/a	n/a
7	BHLHE40	chr9:17493831-17493973	K562	blood:	n/a	n/a
8	BHLHE40	chr9:17462961-17463213	GM12878	blood:	n/a	n/a
9	BRCA1	chr9:17396862-17396940	H1-hESC	embryonic stem cell:	n/a	n/a
10	BRCA1	chr9:17578871-17579210	Hela-S3	cervix:	n/a	n/a
11	BRCA1	chr9:17579040-17579237	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr9:17406793-17407054	IMR90	lung:	n/a	chr9:17406919-17406930 chr9:17406918-17406931
13	CEBPB	chr9:17526868-17527080	HepG2	liver:	n/a	chr9:17526931-17526942
14	CEBPB	chr9:17464916-17465245	HepG2	liver:	n/a	n/a
15	CEBPB	chr9:17440917-17441132	HepG2	liver:	n/a	chr9:17441002-17441013
16	CEBPB	chr9:17594289-17594350	HepG2	liver:	n/a	n/a
17	CEBPB	chr9:17440906-17441152	IMR90	lung:	n/a	chr9:17441002-17441013
18	CEBPB	chr9:17397502-17397682	IMR90	lung:	n/a	n/a
19	CEBPB	chr9:17565909-17566256	IMR90	lung:	n/a	chr9:17566093-17566104
20	CEBPB	chr9:17398398-17398610	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr9:17592528-17592872	IMR90	lung:	n/a	chr9:17592694-17592705
22	CEBPB	chr9:17587199-17587501	HepG2	liver:	n/a	chr9:17587326-17587337
23	CEBPB	chr9:17531531-17531857	A549	lung:	n/a	n/a
24	CEBPB	chr9:17464930-17465234	A549	lung:	n/a	n/a
25	CEBPB	chr9:17526797-17527073	H1-hESC	embryonic stem cell:	n/a	chr9:17526931-17526942
26	CEBPB	chr9:17565992-17566243	H1-hESC	embryonic stem cell:	n/a	chr9:17566093-17566104
27	CEBPB	chr9:17458820-17458969	HepG2	liver:	n/a	chr9:17458858-17458869 chr9:17458860-17458869 chr9:17458858-17458871 chr9:17458859-17458870
28	CEBPB	chr9:17578952-17579084	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr9:17423031-17423372	IMR90	lung:	n/a	n/a
30	CEBPB	chr9:17584689-17584710	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr9:17587142-17587477	ECC-1	luminal epithelium:	n/a	chr9:17587326-17587337
32	CEBPB	chr9:17531544-17532002	H1-hESC	embryonic stem cell:	n/a	n/a
33	CEBPB	chr9:17587171-17587497	H1-hESC	embryonic stem cell:	n/a	chr9:17587326-17587337
34	CEBPB	chr9:17458729-17459037	IMR90	lung:	n/a	chr9:17458858-17458869 chr9:17458860-17458869 chr9:17458858-17458871 chr9:17458859-17458870
35	CEBPB	chr9:17587205-17587469	Hela-S3	cervix:	n/a	chr9:17587326-17587337
36	CEBPB	chr9:17526753-17527068	IMR90	lung:	n/a	chr9:17526931-17526942
37	CEBPB	chr9:17440948-17441127	A549	lung:	n/a	chr9:17441002-17441013
38	CEBPB	chr9:17398373-17398650	IMR90	lung:	n/a	n/a
39	CEBPB	chr9:17437376-17437608	A549	lung:	n/a	chr9:17437440-17437453 chr9:17437442-17437451 chr9:17437442-17437451 chr9:17437440-17437453 chr9:17437442-17437453 chr9:17437442-17437451 chr9:17437442-17437453 chr9:17437440-17437453 chr9:17437442-17437451
40	CEBPB	chr9:17464897-17465248	IMR90	lung:	n/a	n/a
41	CEBPB	chr9:17565950-17566237	HepG2	liver:	n/a	chr9:17566093-17566104
42	CEBPB	chr9:17494858-17494998	H1-hESC	embryonic stem cell:	n/a	n/a
43	CEBPB	chr9:17565934-17566222	Hela-S3	cervix:	n/a	chr9:17566093-17566104
44	CEBPB	chr9:17565911-17566238	A549	lung:	n/a	chr9:17566093-17566104
45	CEBPB	chr9:17592526-17592860	A549	lung:	n/a	chr9:17592694-17592705
46	CEBPB	chr9:17457566-17457746	HepG2	liver:	n/a	chr9:17457686-17457697
47	CEBPB	chr9:17419882-17420104	H1-hESC	embryonic stem cell:	n/a	n/a
48	CEBPB	chr9:17526800-17527071	MCF-7	breast:	n/a	chr9:17526931-17526942
49	CEBPB	chr9:17437391-17437559	H1-hESC	embryonic stem cell:	n/a	chr9:17437440-17437453 chr9:17437442-17437451 chr9:17437442-17437451 chr9:17437440-17437453 chr9:17437442-17437453 chr9:17437442-17437451 chr9:17437442-17437453 chr9:17437440-17437453 chr9:17437442-17437451
50	CEBPB	chr9:17526883-17527024	Hela-S3	cervix:	n/a	chr9:17526931-17526942

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:17579227-17579277	HEEpiC	esophagus:	n/a
2	chr9:17578174-17578224	MCF10A-Er-Src	breast:	n/a
3	chr9:17503269-17503319	HRCEpiC	kidney:	n/a
4	chr9:17579026-17579076	GM12892	blood:	n/a
5	chr9:17503269-17503319	AG09319	gingival:	n/a
6	chr9:17591842-17591892	HMEC	breast:	n/a
7	chr9:17579026-17579076	A549	lung:	n/a
8	chr9:17578779-17578829	ECC-1	luminal epithelium:	n/a
9	chr9:17579734-17579784	HCT-116	colon:	n/a
10	chr9:17503269-17503319	HCM	heart:	n/a
11	chr9:17579734-17579784	HRCEpiC	kidney:	n/a
12	chr9:17579227-17579277	AoSMC	blood vessel:	n/a
13	chr9:17579227-17579277	SK-N-SH_RA	brain:	n/a
14	chr9:17579227-17579277	SK-N-SH	brain:	n/a
15	chr9:17579026-17579076	NH-A	brain:	n/a
16	chr9:17578725-17578775	SK-N-SH	brain:	n/a
17	chr9:17578725-17578775	AG04449	skin:	fetal
18	chr9:17579026-17579076	NHBE	bronchial:	n/a
19	chr9:17578725-17578775	GM12892	blood:	n/a
20	chr9:17578779-17578829	SKMC	muscle:	n/a
21	chr9:17579734-17579784	Jurkat	blood:	n/a
22	chr9:17503269-17503319	HNPCEpiC	eye:	n/a
23	chr9:17591842-17591892	LNCaP	prostate:	n/a
24	chr9:17579734-17579784	AG04449	skin:	fetal
25	chr9:17579026-17579076	HUVEC	blood vessel:	n/a
26	chr9:17591842-17591892	AG09309	skin:	n/a
27	chr9:17578725-17578775	Jurkat	blood:	n/a
28	chr9:17578725-17578775	GM12878	blood:	n/a
29	chr9:17503269-17503319	A549	lung:	n/a
30	chr9:17578779-17578829	BJ	skin:	n/a
31	chr9:17578174-17578224	AG04450	lung:	fetal
32	chr9:17579026-17579076	HAEpiC	amniotic membrane:	n/a
33	chr9:17503269-17503319	CMK	blood:	n/a
34	chr9:17503269-17503319	NB4	blood:	n/a
35	chr9:17578174-17578224	CMK	blood:	n/a
36	chr9:17503269-17503319	LNCaP	prostate:	n/a
37	chr9:17579026-17579076	IMR90	lung:	fetal
38	chr9:17579227-17579277	HCM	heart:	n/a
39	chr9:17503269-17503319	SK-N-MC	brain:	n/a
40	chr9:17579026-17579076	HCPEpiC	choroid plexus:	n/a
41	chr9:17503269-17503319	SAEC	small airway:	n/a
42	chr9:17579227-17579277	AG10803	skin:	n/a
43	chr9:17579227-17579277	HRPEpiC	eye:	n/a
44	chr9:17578174-17578224	HL-60	blood:	n/a
45	chr9:17591842-17591892	HCT-116	colon:	n/a
46	chr9:17578725-17578775	IMR90	lung:	fetal
47	chr9:17591842-17591892	SK-N-SH	brain:	n/a
48	chr9:17578779-17578829	LNCaP	prostate:	n/a
49	chr9:17591842-17591892	MCF-7	breast:	n/a
50	chr9:17578779-17578829	HEEpiC	esophagus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:34498444..34499344-chr9:17525014..17525908,2	MCF-7	breast:
2	chr9:17531556..17532244-chr9:17793906..17794864,2	MCF-7	breast:
3	chr9:17531372..17532326-chr9:17801979..17802845,5	MCF-7	breast:
4	chr9:17531412..17532247-chr9:18212958..18213842,2	MCF-7	breast:
5	chr9:17116081..17117141-chr9:17402172..17402905,3	MCF-7	breast:
6	chr9:17219375..17219930-chr9:17402045..17403347,3	MCF-7	breast:
7	chr9:17116046..17116795-chr9:17462771..17463533,2	MCF-7	breast:
8	chr9:17219155..17220052-chr9:17401883..17402825,5	MCF-7	breast:
9	chr9:17116233..17116835-chr9:17462927..17463473,2	MCF-7	breast:
10	chr9:17063303..17064146-chr9:17462547..17463504,3	MCF-7	breast:
11	chr9:17528534..17529118-chr9:18207797..18208372,2	MCF-7	breast:
12	chr9:17531221..17532407-chr9:17801949..17802935,11	MCF-7	breast:
13	chr9:17528626..17529303-chr9:17802052..17802868,3	MCF-7	breast:
14	chr9:17531792..17532337-chr9:17794326..17794832,2	MCF-7	breast:
15	chr9:17219048..17219921-chr9:17462587..17463121,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SH3GL2-2	chr9:17444195-17444244	NONHSAT130301
2	lnc-SH3GL2-2	chr9:17415964-17416187	NONHSAT130301
3	lnc-BNC2-5	chr9:17590903-17591316	NONHSAT130305
4	lnc-BNC2-4	chr9:17447143-17448541	NONHSAT130303
5	lnc-SH3GL2-2	chr9:17457522-17457626	NONHSAT130301
6	lnc-SH3GL2-2	chr9:17462914-17462982	NONHSAT130301
7	lnc-SH3GL2-2	chr9:17415816-17415879	NONHSAT130301
8	lnc-BNC2-5	chr9:17589159-17590751	NONHSAT130305
9	lnc-SH3GL2-1	chr9:17435732-17437445	NONHSAT130302
10	lnc-CNTLN-5	chr9:17579080-17579285	NONHSAT130304

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	CNTLN	hsa-miR-26b-5p	chr9:17503103-17503123

Variant related genes	Relation type
ENSG00000224488	TF binding region
CNTLN	TF binding region
SH3GL2	TF binding region
PABPC1P11	TF binding region
ENSG00000224488	CpG island
CNTLN	CpG island
SH3GL2	CpG island
PABPC1P11	CpG island

Extended variants
information (count: 7439 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:7439 , 50 per page) page: 1 2 3 4 5 6 7 ... 149

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548849589	chr9:17396770-17396771	Flanking Active TSS Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs567250799	chr9:17396790-17396791	Flanking Active TSS Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs529221725	chr9:17396927-17396928	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs550707950	chr9:17396970-17396971	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs569288190	chr9:17396981-17396982	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs539549006	chr9:17397011-17397012	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs558273932	chr9:17397022-17397023	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs12000092	chr9:17397061-17397062	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs189763704	chr9:17397091-17397092	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs10810784	chr9:17397101-17397102	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs574404041	chr9:17397162-17397163	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs544190304	chr9:17397201-17397202	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs555892268	chr9:17397295-17397296	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs35316342	chr9:17397342-17397343	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs577616729	chr9:17397351-17397352	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs544769814	chr9:17397355-17397356	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs10756879	chr9:17397381-17397382	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs565953207	chr9:17397427-17397428	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs527461979	chr9:17397433-17397434	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs542436512	chr9:17397445-17397446	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs560809110	chr9:17397451-17397452	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs138964555	chr9:17397494-17397495	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs115977491	chr9:17397524-17397525	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs7874945	chr9:17397549-17397550	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs112059300	chr9:17397569-17397570	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs182304220	chr9:17397578-17397579	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs112950459	chr9:17397609-17397610	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs576729510	chr9:17397625-17397626	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs186919175	chr9:17397662-17397663	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs368814357	chr9:17397664-17397665	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs368491894	chr9:17397665-17397666	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs192789075	chr9:17397672-17397673	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs7048330	chr9:17397679-17397680	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs549611131	chr9:17397681-17397682	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs567914495	chr9:17397686-17397687	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs140571260	chr9:17397695-17397696	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs556858534	chr9:17397715-17397716	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs577552005	chr9:17397756-17397757	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs538657706	chr9:17397798-17397799	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs185127875	chr9:17397866-17397867	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs370460377	chr9:17397916-17397917	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs553559467	chr9:17397918-17397919	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs188398365	chr9:17397960-17397961	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs145707262	chr9:17398046-17398047	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs542366996	chr9:17398047-17398048	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs62559022	chr9:17398056-17398057	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs193228527	chr9:17398069-17398070	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs148079352	chr9:17398088-17398089	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs565210608	chr9:17398092-17398093	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs376274932	chr9:17398105-17398106	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD
Renal cell carcinoma	21215367	CNVD
Cancer	22183965	CNVD
Lung adenocarcinoma	21935476	CNVD
Thoracic aortic aneurysm	21698135	CNVD
Pancreatic cancer	21811587	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:845 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:17368400-17457800	Weak transcription	Pancreas	Pancrea
2	chr9:17368600-17411200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
3	chr9:17368600-17411400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
4	chr9:17368600-17411400	Weak transcription	Aorta	Aorta
5	chr9:17368800-17411400	Weak transcription	Duodenum Smooth Muscle	Duodenum
6	chr9:17369400-17411200	Weak transcription	Fetal Muscle Trunk	muscle
7	chr9:17377600-17403000	Weak transcription	Fetal Stomach	stomach
8	chr9:17379400-17404200	Weak transcription	Psoas Muscle	Psoas
9	chr9:17380600-17411000	Weak transcription	Left Ventricle	heart
10	chr9:17381000-17411200	Weak transcription	Fetal Muscle Leg	muscle
11	chr9:17381200-17411200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
12	chr9:17381400-17397400	Weak transcription	Ovary	ovary
13	chr9:17381400-17422800	Weak transcription	Colon Smooth Muscle	Colon
14	chr9:17385400-17411400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr9:17387000-17411200	Weak transcription	Dnd41	blood
16	chr9:17388200-17397200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr9:17388200-17411400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr9:17389000-17404200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr9:17389600-17396800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr9:17391400-17397400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr9:17391600-17411200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
22	chr9:17393400-17400600	Weak transcription	NH-A	brain
23	chr9:17393400-17411400	Weak transcription	Lung	lung
24	chr9:17393400-17433000	Weak transcription	Primary monocytes fromperipheralblood	blood
25	chr9:17393600-17412800	Weak transcription	Fetal Kidney	kidney
26	chr9:17393600-17413000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr9:17393800-17413000	Weak transcription	A549	lung
28	chr9:17394200-17396800	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr9:17394800-17396800	Enhancers	H1 Cell Line	embryonic stem cell
30	chr9:17395000-17398400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
31	chr9:17395200-17397400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr9:17395400-17397400	Weak transcription	Fetal Heart	heart
33	chr9:17395400-17413600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr9:17395400-17417800	Weak transcription	NHDF-Ad	bronchial
35	chr9:17395600-17410600	Weak transcription	Monocytes-CD14+_RO01746	blood
36	chr9:17395600-17411200	Weak transcription	Fetal Lung	lung
37	chr9:17395800-17397200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
38	chr9:17395800-17405000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr9:17396000-17396800	Enhancers	Liver	Liver
40	chr9:17396000-17399200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
41	chr9:17396000-17410800	Weak transcription	Primary hematopoietic stem cells	blood
42	chr9:17396200-17398400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr9:17396200-17413200	Weak transcription	Stomach Smooth Muscle	stomach
44	chr9:17396200-17440000	Weak transcription	Adipose Nuclei	Adipose
45	chr9:17396400-17397000	Enhancers	HUES6 Cell Line	embryonic stem cell
46	chr9:17396400-17398400	Weak transcription	H9 Cell Line	embryonic stem cell
47	chr9:17396600-17396800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
48	chr9:17396600-17396800	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr9:17396600-17397000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
50	chr9:17396600-17397000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links